Free alerts

CRVS insider buying

Every open-market purchase of Corvus Pharmaceuticals, Inc. (CRVS) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$333.65K
Insiders buying (12m)2
Purchases on record2
Last purchase filedJun 15, 2026

In the last 12 months, 2 insiders of Corvus Pharmaceuticals, Inc. bought $333.65K of CRVS stock on the open market in 2 reported purchases. The most recent was filed on Jun 15, 2026: Moore David Scott (Director) bought 21,700 shares at $11.53, worth $250.20K.

Get the next CRVS insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All CRVS insider purchases

FiledInsiderValueSharesPriceStakeTrade
Jun 15Moore David ScottDirector$250.20K21,700$11.53newJun 11SEC
May 20Miller Richard A MdPresident and CEO, Director$83.45K6,932$12.04+1%May 18SEC